We believe that there is and will always be a place for human intervention – a place for people to apply their design, construction and engineering know-how – it’s just about taking the tedious repetitive tasks away from humans and getting them to do the bits they’re good at.

“The layout, space and light in the milling building is superb,” said Pfizer’s Senior Director of Operations..The Singapore API plant is the 2024 FOYA Category Winner for Operations, Project Execution.

This is thanks to the whole project team's successful delivery of a large and complex project ahead of schedule and under budget during a global pandemic.. GSK Parma Attachment Inhibitor: meeting a life-saving need.Aiming to introduce manufacturing capability into GSK’s Parma site for Fostemsavir (a life-saving HIV drug for patients with limited or no other treatment options available), this project’s brief was ambitious.. To maintain supply while the drug was in development and clinical trials, GSK had to build and commission a brand new facility in a shorter timeframe than had ever been achieved before.. As lead designer, Bryden Wood formed a collaborative team with external partners and client representatives to capture functional requirements in “Chip” models that could be rapidly configured to allow many design options to be evaluated in a short time..The ability to undertake rapid digital optioneering was particularly important as forecast demand volumes were uncertain and clinical manufacturing requirements for the drug were still being developed during the design phase.

We developed a capacity model in-house to inform decisions around unit operations and scale..The final design concept was deliberately simple.

Process spaces were housed on a single level, raised above the ground to meet flood protection requirements.

A technical floor was located above the process.We do not have the luxury of a million years to size our factories.

However, neither should we now be constrained by the size of a human, a building or by the relatively recent economic dogma..I don’t think we can credibly argue that capitalism has not been a key enabler in the rapid technological advancements of the last two to three hundred years.

And when we talk about capitalism, we cannot ignore the name Adam Smith.The problem I have with the way we’ve taken Smith’s thoughts and works is that it is piecemeal and skewed – we’ve latched onto some of his insights without exploring them more widely.